Nelson, Van Denburg & Campbell Wealth Management Group, LLC Neurocrine Biosciences Inc Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

  • $2.42 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$130.86 - $143.19 $107,828 - $117,988
-824 Reduced 19.69%
3,360 $462,000
Q1 2024

Apr 30, 2024
SELL
$130.4 - $143.74 $5,607 - $6,180
-43 Reduced 1.02%
4,184 $577,000
Q4 2023

Jan 30, 2024
SELL
$106.07 - $132.76 $29,911 - $37,438
-282 Reduced 6.25%
4,227 $556,000
Q3 2023

Oct 17, 2023
BUY
$94.02 - $117.1 $180,894 - $225,300
1,924 Added 74.43%
4,509 $507,000
Q2 2023

Jul 19, 2023
BUY
$89.53 - $104.87 $37,065 - $43,416
414 Added 19.07%
2,585 $243,000
Q1 2023

May 10, 2023
SELL
$94.11 - $123.02 $10,446 - $13,655
-111 Reduced 4.86%
2,171 $219,000
Q4 2022

Feb 14, 2023
SELL
$106.72 - $127.06 $170,965 - $203,550
-1,602 Reduced 41.25%
2,282 $272,000
Q3 2022

Oct 26, 2022
SELL
$92.03 - $107.81 $51,628 - $60,481
-561 Reduced 12.62%
3,884 $412,000
Q2 2022

Aug 10, 2022
SELL
$75.79 - $100.07 $105,120 - $138,797
-1,387 Reduced 23.78%
4,445 $433,000
Q1 2022

May 13, 2022
SELL
$72.45 - $94.81 $227,420 - $297,608
-3,139 Reduced 34.99%
5,832 $546,000
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $66,507 - $88,693
835 Added 10.26%
8,971 $764,000
Q3 2021

Nov 02, 2021
BUY
$86.18 - $99.03 $89,196 - $102,496
1,035 Added 14.58%
8,136 $780,000
Q2 2021

Jul 27, 2021
BUY
$89.43 - $102.27 $6,349 - $7,261
71 Added 1.01%
7,101 $691,000
Q1 2021

May 11, 2021
BUY
$87.57 - $119.4 $80,126 - $109,251
915 Added 14.96%
7,030 $683,000
Q4 2020

Feb 09, 2021
BUY
$86.91 - $108.33 $74,742 - $93,163
860 Added 16.37%
6,115 $586,000
Q3 2020

Oct 20, 2020
BUY
$96.16 - $135.15 $43,272 - $60,817
450 Added 9.37%
5,255 $504,000
Q2 2020

Jul 02, 2020
BUY
$85.09 - $130.36 $8,509 - $13,036
100 Added 2.13%
4,805 $586,000
Q1 2020

Apr 01, 2020
BUY
$75.11 - $113.76 $350,012 - $530,121
4,660 Added 10355.56%
4,705 $407,000
Q4 2019

Feb 11, 2020
BUY
$86.8 - $118.57 $3,906 - $5,335
45 New
45 $4,000
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $218,887 - $276,548
-3,030 Closed
0 $0
Q1 2019

May 08, 2019
BUY
$69.31 - $91.53 $63,072 - $83,292
910 Added 42.92%
3,030 $266,000
Q4 2018

Feb 13, 2019
BUY
$68.32 - $124.36 $62,171 - $113,167
910 Added 75.21%
2,120 $151,000
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $126,467 - $160,962
-1,279 Reduced 51.39%
1,210 $149,000
Q2 2018

Aug 16, 2018
BUY
$75.3 - $105.99 $94,727 - $133,335
1,258 Added 102.19%
2,489 $245,000
Q1 2018

May 15, 2018
BUY
$75.88 - $92.43 $8,422 - $10,259
111 Added 9.91%
1,231 $102,000
Q4 2017

Feb 08, 2018
BUY
$58.53 - $77.59 $65,553 - $86,900
1,120
1,120 $87,000

Others Institutions Holding NBIX

# of Institutions
627
Shares Held
94.3M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email